4 recruiting, 1 not yet recruiting, 1 terminated. 1 Early Phase 1, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Not yet recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Stroke (in Patients With Atrial Fibrillation): new trials by email Literature Review of Stroke (in Patients With Atrial Fibrillation) trials Research Report on Stroke (in Patients With Atrial Fibrillation)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Atrial Fibrillation TRIal of Left Atrial Appendage Closure Using Seralene Hemostatic Suture LAA closure using the AtriLASH - ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION, Atrial Fibrillation (AF) | Not applicable | Recruiting | Institute of Cardiovascular Diseases, Vojvodina | 200 | 2025-12-01 | 2026-01-22 |
| DOAC or VKA in Patients With AF and Stroke While on DOAC - a Pilot Trial VKA, Direct Oral Anticoagulant (DOAC) - Atrial Fibrillation (AF), Stroke (in Patients With Atrial Fibrillation) | Early Phase 1 | Not yet recruiting | Population Health Research Institute | 100 | 2025-09-03 | 2025-06-08 |
| Thrombolysis in Factor Xa-inhibitors Trial thrombolysis therapy - Stroke, Stroke (in Patients With Atrial Fibrillation) | Phase 3 | Recruiting | Guri Hagberg | 300 | 2025-03-14 | 2026-11-04 |
| Heat Shock Protein 47 in Thrombosis Venous Thromboembolism (VTE), Acute Myocardial Infarction With ST Segment Elevation | Recruiting | University of Aarhus | 340 | 2024-12-09 | 2025-08-21 | |
| Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion Atrial Fibrillation (AF), Atrial Fibrillation (Prevention of Stroke) | Recruiting | Nedim Tojaga | 150 | 2024-08-16 | 2025-04-29 | |
| A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses. DPOC-4088, Placebo - Deep Vein Thrombosis Leg, Stroke (in Patients With Atrial Fibrillation) | Phase 1 | Terminated | Diakron Pharmaceuticals | 30 | 2012-02-01 | 2015-02-24 |
Stroke (6) · Atrial Fibrillation (3) · Intracranial Hemorrhages (1) · Ischemic Stroke (1) · Thrombosis (1) · Venous Thromboembolism (1) · Venous Thrombosis (1)
Brain Diseases (6) · Cardiovascular Diseases (6) · Central Nervous System Diseases (6) · Cerebrovascular Disorders (6) · Nervous System Diseases (6) · Vascular Diseases (6) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Arrhythmias, Cardiac (3) · Embolism and Thrombosis (3) · Heart Diseases (3) · Hemorrhage (1) · Thromboembolism (1) · Thrombosis (1)
Dabigatran (1) · N(4)-oleylcytosine arabinoside (1) · Rivaroxaban (1) · Tenecteplase (1) · Thrombolytic Therapy (1) · Tissue Plasminogen Activator (1) · apixaban (1)
Diakron Pharmaceuticals (1) · Guri Hagberg (1) · Institute of Cardiovascular Diseases, Vojvodina (1) · Nedim Tojaga (1) · Population Health Research Institute (1) · University of Aarhus (1)
Denmark (3) · Belgium (1) · Germany (1) · Norway (1) · Serbia (1) · Sweden (1)
Luc M van Bortel, Prof. Dr. (1)
2023 (1)